Real Brokerage Clears HSR Antitrust Review for $880M RE/MAX Acquisition
REAX sits 31% above its 52-week low of $1.55.
Summary
Real Brokerage received early HSR antitrust clearance for its $880 million RE/MAX acquisition, a critical step that reduces regulatory risk and paves the way for shareholder votes in August.
Key Events · M&A and Partnerships · REAX
-
HSR Antitrust Clearance Obtained
On July 13, 2026, the U.S. Department of Justice granted early termination of the Hart-Scott-Rodino waiting period, clearing a key regulatory condition for the $880 million RE/MAX acquisition.
-
Deal Remains on Track for August Close
With HSR clearance now secured, the merger awaits shareholder votes at meetings scheduled for August 2026, as outlined in the definitive proxy materials mailed on July 9, 2026.
-
Regulatory Risk Materially Reduced
The early termination indicates no antitrust concerns, removing a significant overhang and increasing the probability of deal completion.
-
Next Milestone: Shareholder Votes
Shareholders of Real Brokerage and RE/MAX Holdings are set to vote on the merger in August 2026; approval would allow the transaction to close shortly thereafter.
Analysis · REAX · Real Estate & Construction
A major regulatory hurdle fell away on July 13, 2026, when the U.S. Department of Justice granted early termination of the HSR waiting period for Real Brokerage's $880 million acquisition of RE/MAX Holdings. The clearance materially de-risks the transaction, which still needs shareholder approvals at meetings scheduled for August 2026. Coming just days after proxy materials were mailed, the early termination signals no antitrust concerns and keeps the merger on track for a timely close.
At the time of this filing, REAX was trading at $2.03 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $444.2M. The 52-week trading range was $1.55 to $5.41. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.